Latest News

Date Title Topic
27 Nov 2017 Withdrawal of the Marketing Authorisation Application for Biosimilar Bevacizumab (Kyomarc) Anticancer agents & Biologic therapy
24 Nov 2017 Withdrawal of the Application for a Change to the EU Marketing Authorisation for Pembrolizumab Lung and other thoracic tumours - Cancer Immunology and Immunotherapy
23 Nov 2017 FDA Approves Emicizumab-kxwh for Prevention and Reduction of Bleeding in Patients with Haemophilia A with Factor VIII Inhibitors Haematologic malignancies
22 Nov 2017 FDA Approves Obinutuzumab for Previously Untreated Follicular Lymphoma Haematologic malignancies - Anticancer agents & Biologic therapy
21 Nov 2017 No Impact of Low Molecular Weight Heparin in Localised Lung Cancer Lung and other thoracic tumours
20 Nov 2017 FDA Approves Sunitinib Malate for Adjuvant Treatment of RCC Genitourinary cancers - Anticancer agents & Biologic therapy
Certificate of Attendance
19 Nov 2017 Cost Benefit Analysis in Hong Kong Decides Against Adding Abiraterone Plus Prednisone to ADT in Metastatic Hormone Sensitive Prostate Cancer Genitourinary cancers - Bioethics, legal and economic issues - Anticancer agents & Biologic therapy
19 Nov 2017 Genomic Data May Provide Therapeutic Options in Advanced HCC Gastrointestinal cancers - Translational research
19 Nov 2017 Appetite Stimulants May Provide the Most Rapid Improvement in Cachexia Palliative and supportive care
18 Nov 2017 Fewer Surgery-Related Complications Reported With Robotic Assisted Surgery Head and neck cancers - Gastrointestinal cancers - Gynaecologic malignancies